Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Muscle Nerve. 2017 Dec 20;57(6):927–931. doi: 10.1002/mus.26032

Table 2.

Immunomodulation therapy exposure

Agent Number of Patients
(%)
Mean Average Annual
Exposure (SD)
Corticosteroid 465 (73.7) 11.8 (17.8)
IVIG 185 (29.3) 0.2 (0.3)
Plasmapheresis 78 (12.4) 0.2 (0.3)
Mycophenolate mofetil 208 (33.0) 1.6 (1.8)
Azathioprine 126 (20.0) 0.5 (0.8)
Cyclosporine 57 (9.0) 0.2 (0.3)
Methotrexate 76 (12.0) 0.7 (0.7)

SD: Standard deviation, IVIG: intravenous immunoglobulin